Stellenwert der medikamentösen Pfortaderdrucksenkung im Therapiekonzept der Varizenblutung

Schlüsselwörter

portale Hypertension - Pfortaderdrucksenkung - Ösophagusvarizen - Varizenblutung - Lebervenenverschlussdruckmessung

Keywords

portal hypertension - portal pressure reduction - oesophageal varices - variceal bleeding - hepatic venous pressure gradient

Literatur

• 1 Abid S, Jafri W, Hamid S, Salih M, Atam Z, Mumtaz K, Shah H A, Abbas Z. Terlipressin vs. Octreotide in bleeding esophageal varices as an adjuvant therapy with endoscopic band ligation: a randomized, double-blind, placebo-controlled trial.  Am J Gastroenterol. 2009;  104 617-623
• 2 Abraldes J, Villanueva C, Banares R. et al . Hepatic venous pressure gradient and prognosis in patients with acute variceal bleeding treated with pharmacologic and endoscopic therapy.  J Hepatol. 2008;  48 229-236
• 3 Armonis A, Patch D, Burroughs A. Hepatic venous pressure measurement: an old test as a new prognostic marker in cirrhosis?.  Hepatology. 1997;  25 245-248
• 4 Avgerinos A, Nevens F, Raptis S, Fevery J. Early administration of somatostatin and efficacy of sclerotherapy in acute oesophageal variceal bleeds: The European Acute Bleeding Oesophageal Variceal Episodes (ABOVE) randomized trial.  Lancet. 1997;  350 1495-1499
• 5 Baik S K, Jeong P H, Ji S W. et al . Acute hemodynamic effects of octreotide and terlipressin in patients with cirrhosis: a randomized comparison.  Am J Gastroentrol. 2005;  100 631-635
• 6 Banares R, Albillos A, Rincon D. et al . Endoscopic treatment versus endoscopic plus pharmacologic treatment for acute variceal bleeding: a meta-analysis.  Hepatology. 2002;  35 609-615
• 7 Bernard B, Grange J, Khac E N. et al . Antibiotic prophylaxis for the prevention of bacterial infections in cirrhotic patients with gastrointestinal bleeding: a meta-analysis.  Hepatology. 1999;  29 1655-1661
• 8 Cales P, Masliah C, Bernard B. et al . Early administration of vapreotide for variceal bleeding in patients with cirrhosis.  N Engl J Med. 2001;  344 23-28
• 9 Cirera I, Feu F, Luca A. et al . Effects of bolus injections and continuous infusions of somatostatin and placebo in patients with cirrhosis: a double-blind hemodynamic investigation.  Hepatology. 1995;  22 106-111
• 10 de Franchis R. Evolving consensus in portal hypertension. Report of the Baveno IV consensus workshop on methodology of diagnosis and therapy of portal hypertension.  J Hepatol. 2005;  43 167-176
• 11 de la Pena J, Brullet E, Sanchez-Hernandez E. et al . Variceal ligation plus nadolol compared with ligation for prophylaxis of variceal rebleeding: a multicenter trial.  Hepatology. 2005;  41 572-578
• 12 Garcia-Pagan J C, Caca K, Bureau C. et al . An early decision for PTFE-TIPS improves survival in high risk cirrhotic patients admitted with an acute variceal bleeding. A multicenter RCT (Abstract).  J Hepatol. 2008;  48 (Suppl 2) S371
• 13 Garcia-Pagan J C, Villanueva C, Albillos A. et al . Nadolol plus isosorbide mononitrate alone or associated with band ligation in the prevention of variceal rebleeding: a multicenter randomized controlled trial.  Gut. 2009;  58 1144-1145
• 14 Gluud L, Klingenberg S, Nikolova D. et al . Banding ligation versus beta-blockers as primary prophylaxis in esophageal varices: systematic review of randomized trials.  Am J Gastroenterol. 2007;  102 2842-288
• 15 Gotzsche P C, Hrobjartsson A. Somatostatin analogues for acute bleeding esophageal varices. Cochrane Database Syst Rev 2008 CD000193
• 16 Groszmann R, Garcia-Tsao G, Bosch J. et al . Beta-blockers to prevent gastroesophageal varices in patients with cirrhosis.  N Engl J Med. 2005;  353 2254-2261
• 17 Groszmann R J, Loureiro-Silva M, Tsai M H. The biology of portal hypertension, 4th ed. Philadelphia; Lippincott Williams & Wilkins 2001
• 18 Hillon P, Lebrec D, Munoz C. et al . Comparison of the effects of a cardioselective and a nonselective betablocker on portal hypertension in patients with cirrhosis.  Hepatology. 1982;  2 528-532
• 19 Hou M C, Lin H C, Liu T T. et al . Antibiotic prophylaxis after endoscopic therapy prevents rebleeding in acute variceal hemorrhage: a randomized trial.  Hepatology. 2004;  39 746-753
• 20 Ioannou G, Doust J, Rockey D C. Terlipressin for acute variceal hemorrhage. Cochrane Database Syst Rev 2003 CD002147
• 21 Lo G H, Chen W C, Chen M H. et al . Banding ligation versus nadolol and isosorbide mononitrate for the prevention of esophageal variceal rebleeding.  Gastroenterology. 2002;  123 728-734
• 22 Lo G H, Chen W C, Lin C K. et al . Improved survival in patients receiving medical therapy as compared with banding ligation for the prevention of esophageal variceal rebleeding.  Hepatology. 2008;  48 580-587
• 23 Lo G H, Chen W C, Wang H M. et al . Low-dose terlipressin plus banding ligation vs. low-dose terlipressin alone in the prevention of very early rebleeding of esophageal varices.  2009, in press;  Gut.
• 24 Merkel C, Marin R, Angeli P. et al . A placebo-controlled clinical trial of nadolol in the prophylaxis of growth of small esophageal varices in cirrhosis.  Gastroenterology. 2004;  127 476-484
• 25 Monescillo A, Martinez-Lagares F, Ruiz del Arbol L. et al . Influence of portal hypertension and its early decompression by TIPS placement on the outcome of variceal bleeding.  Hepatology. 2004;  40 793
• 26 Nevens F, van Steenbergen W, Yap S, Fevery J. Assessment of variceal pressure by continuous non-invasive endoscopic registration. A placebo controlled evaluation of the effect of terlipressin and octreotide.  Gut. 1996;  38 129-134
• 27 Patch D, Sabin C, Goulis J. et al . A randomized, controlled trial of medical therapy versus endoscopic ligation for the prevention of variceal rebleeding in patients with cirrhosis.  Gastroenterology. 2002;  123 1013-1019
• 28 Poynard T, Cales P, Pasta L. et al . Beta-adrenergic-antagonist drugs in the prevention of gastrointestinal bleeding in patients with cirrhosis and esophageal varices.  N Engl J Med. 1991;  324 1532-1538
• 29 Ripoll C, Groszmann R, Garcia-Tsao G. et al . Hepatic venous pressare gradient predicts clinical decompensation in patients with decompensated cirrhosis.  Gastroenterology. 2007;  133 481-488
• 30 Romero G, Kravetz D, Argonz J. et al . Comparative study between nadolol and 5-isosorbide mononitrate vs. endoscopic band ligation plus sclerotherapy in the prevention of variceal rebleeding in cirrhotic patients: a randomized controlled trial.  Aliment Pharmacol Ther. 2006;  24 601-611
• 31 Ruiz del Arbol L, Urman J, Fernandez J. et al . Systemic, renal and hepatic hemodynamic derangement in cirrhotic patients with spontaneous bacterial peritonitis.  Hepatology. 2003;  38 1210-1218
• 32 Sanyal A J, Boyer T, Garcia-Tsao G, Regenstein F, Rossaro L, Appenrodt B, Blei A, Gülberg V, Sigal S, Teuber P. Terlipressin Study Group . A randomized, prospective, double-blind, placebo-controlled trial of terlipressin for type 1 hepatorenal syndrome.  Gastroenterology. 2008;  134 1360-1368
• 33 Schepke M, Kleber G, Nurnberg D. et al . German Study Group for the Primary Prophylaxis of Variceal Bleeding. Ligation versus propranolol for the primary prophylaxis of variceal bleeding in cirrhosis.  Hepatology. 2004;  40 65-72
• 34 Schepke M, Werner E, Biecker E. et al . Hemodynamic effects of the angiotensin II receptor antagonist irbesartan in patients with cirrhosis and portal hypertension.  Gastroenterology. 2001;  121 389-395
• 35 Schepke M, Wiest R, Flacke S. et al . Irbesartan plus low-dose propranolol versus low-dose propranolol alone in cirrhosis: a placebo-controlled, double-blind study.  Am J Gastroenterol. 2008;  103 1152-1158
• 36 Schepke M. Drugs, ligation or both for the prevention of variceal re-bleeding.  Gut. 2009;  58 1045-1046
• 37 Thalheimer U, Leandro G, Samonakis D, Triantos C, Patch D, Burroughs A K. Assessment of the agreement between wedge hepatic vein pressure and portal vein pressure in cirrhotic patients.  Dig Liv Dis. 2005;  37 601-608
• 38 Triantos C, Nikolopoulou V, Burroughs A K. The therapeutic and prognostic benefit of portal pressure reduction in cirrhosis.  Aliment Pharmacol Ther. 2008;  28 943-952
• 39 Tripathi D, Ferguson J W, Kochar N. et al . Multicenter randomized controlled trial of carvedilol versus variceal band ligation for the prevention of the first variceal bleed (Abstract).  Hepatology. 2007;  46 (4, Suppl. 1) 269A
• 40 Villanueva C, Minana J, Ortiz J. et al . Endoscopic ligation compared with combined treatment with nadolol and isosorbide mononitrate to prevent recurrent variceal bleeding.  N Engl J Med. 2001;  345 647-655